Simulations signal early success for fractal-based retinal implants

July 27, 2017, University of Oregon
Credit: CC0 Public Domain

Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing.

That is potential down-the-road good news for people facing vision loss from retinal diseases, such as macular degeneration that, alone, incurs costs exceeding $340 billion globally, according to the Brightfocus Foundation.

"What we've demonstrated is that using a should allow us, in principle, to deliver 20/80 vision," said physics professor Richard P. Taylor, head of the UO's Materials Science Institute.

People with acuity of 20/80 are able to see objects at 20 feet away that those with normal or 20/20 vision can see from a distance of 80 feet. According to the Social Security Act in the United States, any person with a corrected vision of 20/200 or less is considered blind.

In their simulations, the UO researchers studied the performance of their bio-inspired implant, which would be inserted behind the eye's retina. The implant features an array of fractal electrodes designed to stimulate retinal . The results were published in the journal Scientific Reports.

Fractal objects have repeating patterns at many scales and are seen in nature in such things as tree branches, rivers, snowflakes, blood vessels and neurons.

The idea behind Taylor's implant is to exploit electrodes that have the same fractal shape as the neurons with which they will interact. Currently used feature shapes based on traditional Euclidean geometry such as squares.

In human clinical trials with Euclidean-based devices, visual acuity has only achieved 20/1260 for implants placed in front of the retina. Only one patient achieved 20/546 with a device placed behind the retina; 86 percent of cases resulted in no restored acuity, the researchers noted in their paper.

In their computer simulations—done under a grant from the W.M. Keck Foundation - the UO researchers compared the ability of fractal and Euclidean electrodes to stimulate neurons in the retina. The fractal version stimulated 90 percent more neurons while using less voltage.

Because of their repeating patterns, fractal electrodes provide a large surface area that holds more electrical charge than the Euclidean electrodes, said the study's lead author, William J. Watterson, a doctoral student of Taylor's. The large voltage generated by this charge stimulates more neurons.

"Operating under identical conditions in our simulations, we've shown that a single fractal stimulates all of the target neurons, while the Euclidean electrode connects with only 10 percent of them," Watterson said.

Fractal implants, which act much like a pixel array at the back of a camera, can efficiently utilize more pixels within the confined space at the back of the eye, providing electrically-restored vision at a higher resolution, Watterson said. In retina-damaged eyes, the cones and rods that do such intermediate work disappear. The implants would stimulate the still-intact neurons.

There is a long way to go before achieving that reality in people, he said. The simulated results provide information that can help design miniature versions of the implants for testing in mice, where researchers hope to gain a preliminary measure of how well such devices may restore vision to humans.

"We want to make the pixel smaller but make use of ," he said. "In this study, we showed that by just doing a rearrangement of the top electrode into a then we can stimulate the within the open-circuit voltage of silicon photodiodes."

In the eyes, electrical charges come from incoming light.

Taylor's former doctoral student Rick Montgomery, now a data scientist at Fluence Analytics in New Orleans, also was a co-author on the Nature paper.

Pursuit of a fractal-based retinal is covered under a U.S. patent, which applies to any -inspired device designed for biomedical purposes. Taylor, the UO, Taylor's research collaborator Simon Brown, and Brown's home institution, the University of Canterbury in New Zealand, hold the patent.

Explore further: Photovoltaic retinal implant could restore functional sight, researchers say

More information: W. J. Watterson et al, Fractal Electrodes as a Generic Interface for Stimulating Neurons, Scientific Reports (2017). DOI: 10.1038/s41598-017-06762-3

Related Stories

Photovoltaic retinal implant could restore functional sight, researchers say

April 28, 2015
A team led by Stanford University researchers has developed a wireless retinal implant that they say could restore vision five times better than existing devices.

Researchers discover way to improve image sharpness for blind people with retinal implants

December 16, 2015
Retinal implants that deliver longer pulses of electrical current may noticeably improve image sharpness for individuals who have lost their sight due to retinitis pigmentosa, according to a new study by researchers from ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

EmceeSquared
not rated yet Jul 27, 2017
"Pursuit of a fractal-based retinal implant is covered under a U.S. patent, which applies to any fractal-inspired device designed for biomedical purposes."

There are more different fractal patterns than there are different squares (since fractals have more independent parameters than squares do). Yet that patent prohibits anyone else from developing alternate fractal patterns. A patent on "any euclidean-inspired devices designed for biomedical purposes" would be narrower, but still obviously absurd. And these patent holders gained their monopoly without even making a device, but rather through simulations.

It's not just ethically wrong. It severely limits progress in science and the useful arts, the opposite of the Constitutional rationalization for constraining free speech for the benefit of capitalism.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.